Investment objective

To provide long-term capital growth. The fund invests primarily in equity securities of companies throughout the world using a quantitative investment approach. The fund seeks to achieve a reduced level of volatility.

Download fund details    Download fund commentary   

Fund details

Series
Currency
Fund code
MER * (%)
F CAD 35087 0.98%

Portfolio analysis As of Aug 31, 2025

100% 0 %
Equity Fixed Income

Asset mix

Equity Sector Allocation
Health Care20.0%
Consumer Staples19.7%
Communication Services17.8%
Financials12.6%
Utilities8.1%
Industrials7.6%
Information Technology4.9%
Energy4.1%
Consumer Discretionary2.9%
Materials2.2%
Top 10 Holdings
% Assets
Roche Holding AG 3.0%
Johnson & Johnson 3.0%
Altria Group Inc 3.0%
Verizon Communications Inc 3.0%
Automatic Data Processing Inc 3.0%
Colgate-Palmolive Co 3.0%
Procter & Gamble Co 2.9%
Merck & Co Inc 2.9%
Gilead Sciences Inc 2.8%
AT&T Inc 2.7%
Total % of Top 10 Holdings 29.3%

Geographic allocation

Region

Performance analysis

Growth of $10,000 since inception

Calendar returns

Trailing return

1 Mth 3 Mth 6 Mth 1 year 3 years 5 years 10 years Since Inception
0.8 4.7 0.6 9.9 13.7 9.5 8.5 10.2 Fund

Distribution ($)/unit

YTD* 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Total distributions 0.01 1.47 1.02 0.25 0.86 0.32 0.73 0.65 0.93 0.58 0.43
Interest --- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 --- --- ---
Canadian dividends --- 0.03 0.04 0.03 0.03 0.04 0.04 0.04 0.04 0.01 0.01
Foreign dividends --- 0.36 0.40 0.24 0.22 0.33 0.26 0.26 0.27 0.21 0.18
Foreign taxes paid --- -0.05 -0.06 -0.02 -0.03 -0.05 -0.04 -0.05 -0.04 -0.04 -0.03
Capital gains --- 1.14 0.64 --- 0.65 --- 0.46 0.40 0.66 0.39 0.27
Return of capital --- --- --- --- --- --- --- --- --- --- ---

* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.